139 related articles for article (PubMed ID: 22442208)
1. Renal IL-17 expression in human ANCA-associated glomerulonephritis.
Velden J; Paust HJ; Hoxha E; Turner JE; Steinmetz OM; Wolf G; Jabs WJ; Özcan F; Beige J; Heering PJ; Schröder S; Kneißler U; Disteldorf E; Mittrücker HW; Stahl RA; Helmchen U; Panzer U
Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1663-73. PubMed ID: 22442208
[TBL] [Abstract][Full Text] [Related]
2. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
Sanders JS; van Goor H; Hanemaaijer R; Kallenberg CG; Stegeman CA
Nephrol Dial Transplant; 2004 Jun; 19(6):1412-9. PubMed ID: 15034162
[TBL] [Abstract][Full Text] [Related]
3. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis.
Gan PY; Steinmetz OM; Tan DS; O'Sullivan KM; Ooi JD; Iwakura Y; Kitching AR; Holdsworth SR
J Am Soc Nephrol; 2010 Jun; 21(6):925-31. PubMed ID: 20299361
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil Gelatinase-Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting T
Schreiber A; Rousselle A; Klocke J; Bachmann S; Popovic S; Bontscho J; Schmidt-Ott KM; Siffrin V; Jerke U; Ashraf MI; Panzer U; Kettritz R
J Am Soc Nephrol; 2020 Jul; 31(7):1569-1584. PubMed ID: 32487561
[TBL] [Abstract][Full Text] [Related]
5. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner.
Hoshino A; Nagao T; Nagi-Miura N; Ohno N; Yasuhara M; Yamamoto K; Nakayama T; Suzuki K
J Autoimmun; 2008 Aug; 31(1):79-89. PubMed ID: 18501296
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis.
Gan PY; Holdsworth SR; Kitching AR; Ooi JD
Cell Immunol; 2013 Mar; 282(1):21-7. PubMed ID: 23665205
[TBL] [Abstract][Full Text] [Related]
7. Tubular osteopontin expression in patients with ANCA-associated glomerulonephritis.
Nitta K; Horita S; Okano K; Uchida K; Honda K; Koike M; Sekine S; Itabashi M; Tsukada M; Takei T; Suzuki K; Yumura W; Nihei H
Clin Nephrol; 2001 Dec; 56(6):459-66. PubMed ID: 11770797
[TBL] [Abstract][Full Text] [Related]
8. Expression of macrophage migration inhibitory factor in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Taniguchi Y; Yorioka N; Yamashita K; Masaki T; Yamakido M
Clin Nephrol; 2000 Aug; 54(2):147-50. PubMed ID: 10968692
[TBL] [Abstract][Full Text] [Related]
9. [A case of necrotizing crescentic glomerulonephritis in which myeloperoxidase antineutrophil cytoplasmic antibodies (ANCA) reflect the disease activity and recognize various neutrophil cytoplasmic constituents].
Fujimoto T; Kimura A; Ameno M; Shiiki H; Dohi K
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):172-7. PubMed ID: 9134836
[TBL] [Abstract][Full Text] [Related]
10. Interstitial Foxp3-positive T cells may predict renal survival in patients with myeroperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Yoshimura J; Fukami K; Koike K; Nagano M; Matsumoto T; Iwatani R; Kusumoto T; Hazama T; Ueda S; Adachi H; Hirai Y; Takasu K; Ohshima K; Yamagishi S; Okuda S
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):879-83. PubMed ID: 20528980
[TBL] [Abstract][Full Text] [Related]
11. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis.
Cockwell P; Brooks CJ; Adu D; Savage CO
Kidney Int; 1999 Mar; 55(3):852-63. PubMed ID: 10027922
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
14. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
15. Differences between myeloperoxidase-specific and -nonspecific P-ANCA-associated renal disease.
Ohtani H; Wakui H; Komatsuda A; Chyzh KA; Hatakeyama T; Masai R; Okuyama S; Togashi M; Sawada K
Ren Fail; 2007; 29(2):183-7. PubMed ID: 17365934
[TBL] [Abstract][Full Text] [Related]
16. IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis.
Hewins P; Morgan MD; Holden N; Neil D; Williams JM; Savage CO; Harper L
Kidney Int; 2006 Feb; 69(3):605-15. PubMed ID: 16514436
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
Jennette JC; Xiao H; Falk RJ
J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
Schreiber A; Xiao H; Falk RJ; Jennette JC
J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
[TBL] [Abstract][Full Text] [Related]
19. Mast cells and tubulointerstitial fibrosis in patients with ANCA-associated glomerulonephritis.
Otsubo S; Nitta K; Uchida K; Yumura W; Nihei H
Clin Exp Nephrol; 2003 Mar; 7(1):41-7. PubMed ID: 14586742
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Yorioka N; Taniguchi Y; Amimoto D; Ogata S; Sakikubo E; Yamakido M; Naito T; Shimamoto F
Clin Nephrol; 1999 Nov; 52(5):293-6. PubMed ID: 10584992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
